REVLIMID 7.5 MG Israel - inglês - Ministry of Health

revlimid 7.5 mg

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 7.5 mg - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

REVLIMID 7.5 MG Israel - inglês - Ministry of Health

revlimid 7.5 mg

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 7.5 mg - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

SODIUM CHLORIDE VIOSER SOLUTION 0.9 % Israel - inglês - Ministry of Health

sodium chloride vioser solution 0.9 %

eldan electronic instruments co ltd, israel - sodium chloride - solution - sodium chloride 9 mg/ml - sodium chloride - short- term intravascular volume substitution. hypotonic dehydration or isotonic dehydration. vehicle solution for supplementary medication.flued and electrolyte replacement, hypochloremic alkalosis and chloride losses.externally for wound irrigation and moistening of wound tamponades dressing

DEXTROSE VIOSER SOLUTION FOR INFUSION 5 % Israel - inglês - Ministry of Health

dextrose vioser solution for infusion 5 %

eldan electronic instruments co ltd, israel - dextrose anhydrous - solution for infusion - dextrose anhydrous 5 % - vehicle solution for supplementary medication. energy supply, hypertonic dehydration

RINGER LACTATED SOLUTIONVIOSER Israel - inglês - Ministry of Health

ringer lactated solutionvioser

eldan electronic instruments co ltd, israel - calcium chloride dihydrate; potassium chloride; sodium chloride; sodium lactate - solution for infusion - sodium lactate 3.14 g/l; calcium chloride dihydrate 0.26 g/l; potassium chloride 0.41 g/l; sodium chloride 6.02 g/l - electrolytes - source of water and electrolytes. regulation or maintenance of metabolic acidosis (except lactic acidosis)

MARGENZA Israel - inglês - Ministry of Health

margenza

neopharm ltd, israel - margetuximab - solution for injection - margetuximab 25 mg / 1 ml - margetuximab - margenza is indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic her2-positive breast cancer who have received two or more prior anti-her2 regimens, at least one of which was for metastatic disease.

SUNOSI 75 MG Israel - inglês - Ministry of Health

sunosi 75 mg

neopharm ltd, israel - solriamfetol as hydrochloride - film coated tablets - solriamfetol as hydrochloride 75 mg - solriamfetol - sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by primary osa therapy, such as continuous positive airway pressure (cpap).

SUNOSI 150 MG Israel - inglês - Ministry of Health

sunosi 150 mg

neopharm ltd, israel - solriamfetol as hydrochloride - film coated tablets - solriamfetol as hydrochloride 150 mg - solriamfetol - sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by primary osa therapy, such as continuous positive airway pressure (cpap).

RECORLEV Israel - inglês - Ministry of Health

recorlev

neopharm ltd, israel - levoketoconazole - tablets - levoketoconazole 150 mg - recorlev is indicated for the treatment of endogenous hypercortisolemia in adult patients with cushing’s syndrome for whom surgery is not an option or has not been curative.recorlev is not approved for the treatment of fungal infections. the safety and effectiveness of recorlev for the treatment of fungal infections have not been established.

Mazit Capsules  250mg Tanzânia - inglês - Tanzania Medicinces & Medical Devices Authority

mazit capsules 250mg

neopharma, united arab emirates - azithromycin - capsules - 250mg